Literature DB >> 19564546

Plasma-mediated vascular dysfunction in the reduced uterine perfusion pressure model of preeclampsia: a microvascular characterization.

Sarah K Walsh1, Fred A English, Edward J Johns, Louise C Kenny.   

Abstract

Preeclampsia is associated with widespread maternal vascular dysfunction, which is thought to be mediated by circulating factor(s). The aim of the study was to characterize vascular function in the reduced uterine perfusion pressure (RUPP) rat model of preeclampsia and to investigate the role of plasma factors in mediating any observed changes in vascular reactivity. Mean arterial blood pressure and vascular function were measured in RUPP and control rats. Mesenteric vessels from both virgin and pregnant rats were exposed for 1 hour or overnight to plasma from both RUPP and control rats and their vascular function assessed. RUPP rats were characterized by severe hypertension, restricted fetal growth, and reduced placental weight (P<0.001). Vasorelaxation was impaired in resistance vessels from RUPP compared with control rats (acetylcholine: R(max) 70+/-3 versus 92+/-1 [NP] and 93+/-3% [sham], P<0.01; bradykinin: 40+/-2 versus 62+/-2 [NP] and 59+/-4% [sham], P<0.001). Incubation of vessels from pregnant (but not virgin) animals with RUPP plasma overnight resulted in an attenuation of vasorelaxant responses (acetylcholine: 63+/-7 versus 86+/-2%, P<0.05; bradykinin: 35+/-5 versus 55+/-6%, P<0.001). The residual relaxant response in RUPP plasma-treated vessels was not further attenuated after treatment with N(omega)-nitro-l-arginine methyl ester (acetylcholine: 57+/-7 versus 63+/-7%, ns; bradykinin: 37+/-5 versus 35+/-5%, ns). The RUPP rat model is characterized by an impaired response to vasodilators which may be attributable to one or more circulating factors. This plasma-mediated endothelial dysfunction appears to be a pregnancy-dependent effect. Furthermore, nitric oxide-mediated vasorelaxation appears to be absent in RUPP plasma-treated vessels.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19564546     DOI: 10.1161/HYPERTENSIONAHA.109.132191

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  27 in total

1.  Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia.

Authors:  Ossama M Reslan; Raouf A Khalil
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2010-10-01

2.  Interleukin-17 signaling mediates cytolytic natural killer cell activation in response to placental ischemia.

Authors:  Olivia K Travis; Dakota White; Cedar Baik; Chelsea Giachelli; Willie Thompson; Cassandra Stubbs; Mallory Greer; James P Lemon; Jan Michael Williams; Denise C Cornelius
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-04-22       Impact factor: 3.619

3.  Letter to the Editor: Importance of B cells in response to placental ischemia.

Authors:  Babbette LaMarca
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-03-01       Impact factor: 4.733

4.  Nitric oxide synthase-mediated blood pressure regulation in obese melanocortin-4 receptor-deficient pregnant rats.

Authors:  Frank T Spradley; Jennifer M Sasser; Jacqueline B Musall; Jennifer C Sullivan; Joey P Granger
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-08-17       Impact factor: 3.619

5.  The glucagon-like peptide 1 receptor agonist liraglutide attenuates placental ischemia-induced hypertension.

Authors:  Subhi Talal Younes; Kenji J Maeda; Jennifer Sasser; Michael J Ryan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-11-15       Impact factor: 4.733

6.  Contribution of PARP to endothelial dysfunction and hypertension in a rat model of pre-eclampsia.

Authors:  S K Walsh; F A English; I P Crocker; E J Johns; L C Kenny
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

Review 7.  A model of preeclampsia in rats: the reduced uterine perfusion pressure (RUPP) model.

Authors:  Jing Li; Babbette LaMarca; Jane F Reckelhoff
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-04-20       Impact factor: 4.733

8.  Recent advances in the understanding of the pathophysiology of preeclampsia.

Authors:  Junie P Warrington; Eric M George; Ana C Palei; Frank T Spradley; Joey P Granger
Journal:  Hypertension       Date:  2013-07-29       Impact factor: 10.190

9.  Restoring placental growth factor-soluble fms-like tyrosine kinase-1 balance reverses vascular hyper-reactivity and hypertension in pregnancy.

Authors:  Minglin Zhu; Zongli Ren; José S Possomato-Vieira; Raouf A Khalil
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-06-08       Impact factor: 3.619

10.  Placental ischemia induces changes in gene expression in chorionic tissue.

Authors:  Eric M George; Michael R Garrett; Joey P Granger
Journal:  Mamm Genome       Date:  2014-03-26       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.